Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. - Wikidata - wikimedia - TriplyDB

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

http://www.wikidata.org/entity/Q38487646

about

Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer Patients Unique features of young age breast cancer and its management Strategies for fertility preservation in young patients with cancer: a comprehensive approach Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update Long term side effects of adjuvant chemotherapy in patients with early breast cancer Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women Current state and controversies in fertility preservation in women with breast cancer.Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.Fertility issues of breast cancer survivors.Breast cancer in young women: special considerations in multidisciplinary care.Fertility preservation in women with cancer.Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis.Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age: a summary based on 434 patients Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.Multiple approaches for individualized fertility protective therapy in cancer patients.Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.Major clinical research advances in gynecologic cancer in 2011.Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function.Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients Can We Keep the 'PROMISE'? AGO Breast Commission: Commentary on Recent Evidence Regarding LHRH Analogues for the Preservation of Ovarian Function.Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis.Recommendations for fertility preservation in patients with lymphomas Fertility considerations in young women with hematological malignancies.Hormone Use for Therapeutic Amenorrhea and Contraception During Hematopoietic Cell Transplantation Fertility Preservation Methods in Breast Cancer.Understanding Fertility in Young Female Cancer Patients.Applicability of adult techniques for ovarian preservation to childhood cancer patients.Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis.Treatment for Uterine Fibroids: Searching for Effective Drug Therapies.Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover.Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.Fertility counseling of young breast cancer patients.Preserving Fertility in Children and Adolescents with Cancer.Characterization of the gonadotropin releasing hormone receptor (GnRHR) expression and activity in the female mouse ovary.

P2860

Q26743355-41A85C67-582A-4C01-A3C9-D508B871B96C Q26821902-37E3B490-97A3-41FC-A484-84FB00AA2771 Q27002719-372750CE-4753-4ADD-8E4B-3D9306F8F604 Q28079998-232A6444-4963-42BF-92B2-58FE7FB7712F Q28083233-94966345-4F6D-4799-A97D-C8A718113F92 Q28085062-FE7071B0-5123-47D9-983B-F7FA0D9047B7 Q28275450-572F6CB9-7A1D-44DF-8236-D9FBA407026C Q28383280-7628B5DD-21D1-4AF4-BA30-5FED47818A88 Q28392230-941C7B66-C460-476A-8A40-8E79015AE750 Q33779879-1191EB5C-353B-47AE-A980-38290EA971A0 Q33838766-38A71927-F3E3-487F-924B-C60D241B1E8F Q33885680-9F3A06CB-BBC8-4477-BD73-2EE7D47B29A3 Q34306522-289E7A50-940B-440E-9087-B85B7578196A Q34729392-EAF3F92D-649A-47BA-A2A7-384CBE6D9F67 Q34743455-F8C39DD4-BF8A-423E-838F-EEDD87A9D503 Q34785329-6A999D98-5637-4119-8EE6-25CC84D02E86 Q35060296-AC9BD1A2-67C6-45DB-A9AD-A81DBD478A6C Q35511100-A77CD2DA-5006-4339-ABE3-2DA1F255A639 Q35664417-AA5260C7-92DF-4F33-87F9-72622E41FF95 Q35671371-E5AD1516-D197-40BA-B3C6-20508442774A Q35758722-EDA23E08-61F1-4877-B478-7F25481FCFDB Q35766397-ECB1F628-0699-4E11-B5DD-4392F336D6FC Q35776206-BF6A786A-AF9F-4280-98CC-CDADBC701926 Q35776251-C9DAB531-A3FF-45A7-BA10-294C774D6D81 Q35789448-B8CEC582-44AC-4807-B391-58DF3E01A08A Q35856600-529A4B49-BF3F-4DBB-8EA1-723F10957C60 Q36016176-60916BA6-C737-432A-A7A0-B4F184BAD182 Q36016181-811F86A2-2CA7-4E39-B353-63672557D4FD Q36087035-A74BA493-EDAF-4E95-8F1D-033EC8EA2C51 Q36131370-0F9C129D-3533-45C7-91FD-316B37CA0732 Q36218039-5D1FC259-18D1-4242-9530-E27DA86F69C5 Q36295588-2DC29CB7-B9CF-4ED6-9891-311D5A88D6BB Q36404774-A1E26B74-A413-4F35-A099-A2141964DDC2 Q36476226-B3657B9D-E607-4ABF-97A2-0FDB7771EAE5 Q36478763-788BCD26-333C-47B1-89A7-738D3FA36147 Q36661462-257D7C45-7946-4AED-AE43-AFA7932E412A Q36688597-784BD634-3CC0-49F2-B1F9-3B69E8A18058 Q36963384-3184E7FE-EF2E-4B0D-B536-4B86246ADB7D Q37055811-0E6B75BD-1C92-416F-B305-C2268CC8810B Q37181877-68AC3337-6F57-420F-ACCC-812C136350C8

P2860

Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.

http://www.wikidata.org/entity/Q38487646

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Effect of the gonadotropin-rel ...... st cancer: a randomized trial.

@en

type

label

Effect of the gonadotropin-rel ...... st cancer: a randomized trial.

@en

prefLabel

Effect of the gonadotropin-rel ...... st cancer: a randomized trial.

@en

P1433

Q38487646-F2D405B8-B764-47C7-B15E-A592D979FE82

P1476

Q38487646-0911F085-C63B-4029-A8A9-39836BC17359

P2093

Q38487646-1258C267-B134-4068-A29C-D88D9E6DA1BE

Q38487646-3400A88C-3E95-447A-B9D2-33A3DB8057DF

Q38487646-35D92AB8-486E-405A-86B2-81CF03B927CE

Q38487646-3A3F7A52-B704-42E6-B25E-6AC48A535540

Q38487646-3B9DB45B-68C6-41CA-B8EE-328D15AF3F7B

Q38487646-3F81C905-1F7D-43AD-9204-5FDBE5D1E9B0

Q38487646-568AA072-6219-4B3A-925C-14420F87B4BE

Q38487646-763B4560-3EC4-400F-9E9E-F7248E5C31BA

Q38487646-7E520661-6551-4B35-8BF5-6F23042CC609

Q38487646-91D2A452-EF63-49C3-95D4-69851B492007

P304

Q38487646-46519D01-04FE-4AA3-A77B-DA7A5CDA2DA8

P31

Q38487646-C67EF1B6-6A63-48E1-A36D-D937FA665638

P356

Q38487646-2A7A19E7-C6C7-4B06-ADCD-5C9F6C16F550

P407

Q38487646-623C7615-15BA-45B8-B923-1D5717AAEA79

P433

Q38487646-9C399D7F-C3B4-477F-95B9-177C9F4AF0BD

P478

Q38487646-A1956D86-37CC-4779-A9B1-CB4450883FEE

P50

Q38487646-1ACBAF1B-C598-4400-8A2E-55918C6C71F1

Q38487646-C2D8F11F-7E9A-4257-AD04-50A52881EECD

Q38487646-D3AA6BC4-AFDC-436C-A165-D3A33F0C22FE

Q38487646-F4B8CCB4-99B8-424B-9711-42B635813D31

P577

Q38487646-C4C2BBA6-2D95-420A-82D9-86366FB93493

P5875

Q38487646-F1A2EF31-1A83-4282-8837-306602BCB30A

P698

Q38487646-344E4630-DF73-4D2D-BEDE-7AF3FA563295

P921

Q38487646-07AC1278-3651-4B9B-9B17-197E2206E666

Q38487646-E56ED7C1-1906-4E54-8362-B751CDF0C9C2

P356

P1433

Journal of the American Medical Association

P1476

Effect of the gonadotropin-rel ...... st cancer: a randomized trial.

@en

P2093

Alessia Levaggi

http://www.w3.org/2001/XMLSchema#string

Andrea Michelotti

http://www.w3.org/2001/XMLSchema#string

Carlo Vecchio

http://www.w3.org/2001/XMLSchema#string

Emanuela Magnolfi

http://www.w3.org/2001/XMLSchema#string

Luca Boni

http://www.w3.org/2001/XMLSchema#string

Marco Venturini

http://www.w3.org/2001/XMLSchema#string

Monica Giordano

http://www.w3.org/2001/XMLSchema#string

Nicola Cresti

http://www.w3.org/2001/XMLSchema#string

Nina Olmeo

http://www.w3.org/2001/XMLSchema#string

Ornella Garrone

http://www.w3.org/2001/XMLSchema#string

P304

269-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2011.991

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

306

http://www.w3.org/2001/XMLSchema#string

P50

Lucia Del Mastro

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51504879

http://www.w3.org/2001/XMLSchema#string

P698

21771987

http://www.w3.org/2001/XMLSchema#string

P921